nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP2E1—type 2 diabetes mellitus	0.153	0.387	CbGaD
Bromazepam—CYP1A2—type 2 diabetes mellitus	0.145	0.369	CbGaD
Bromazepam—CYP3A4—type 2 diabetes mellitus	0.0962	0.244	CbGaD
Bromazepam—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0283	0.0872	CbGbCtD
Bromazepam—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.024	0.0742	CbGbCtD
Bromazepam—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.024	0.0742	CbGbCtD
Bromazepam—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0222	0.0685	CbGbCtD
Bromazepam—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0214	0.0661	CbGbCtD
Bromazepam—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0205	0.0632	CbGbCtD
Bromazepam—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.018	0.0556	CbGbCtD
Bromazepam—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0161	0.0497	CbGbCtD
Bromazepam—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0161	0.0496	CbGbCtD
Bromazepam—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0152	0.047	CbGbCtD
Bromazepam—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0147	0.0454	CbGbCtD
Bromazepam—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0128	0.0397	CbGbCtD
Bromazepam—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0123	0.038	CbGbCtD
Bromazepam—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0116	0.0359	CbGbCtD
Bromazepam—CYP2C19—Losartan—type 2 diabetes mellitus	0.0113	0.0347	CbGbCtD
Bromazepam—CYP1A2—Losartan—type 2 diabetes mellitus	0.0104	0.032	CbGbCtD
Bromazepam—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00881	0.0272	CbGbCtD
Bromazepam—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00844	0.0261	CbGbCtD
Bromazepam—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00844	0.0261	CbGbCtD
Bromazepam—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00798	0.0246	CbGbCtD
Bromazepam—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00595	0.0184	CbGbCtD
Bromazepam—CYP3A4—Losartan—type 2 diabetes mellitus	0.00544	0.0168	CbGbCtD
Bromazepam—GABRR3—peripheral nervous system—type 2 diabetes mellitus	0.00403	0.131	CbGeAlD
Bromazepam—GABRR2—peripheral nervous system—type 2 diabetes mellitus	0.00349	0.114	CbGeAlD
Bromazepam—GABRR1—peripheral nervous system—type 2 diabetes mellitus	0.00336	0.109	CbGeAlD
Bromazepam—GABRQ—nerve—type 2 diabetes mellitus	0.00314	0.102	CbGeAlD
Bromazepam—GABRR3—nerve—type 2 diabetes mellitus	0.00314	0.102	CbGeAlD
Bromazepam—GABRR2—nerve—type 2 diabetes mellitus	0.00272	0.0885	CbGeAlD
Bromazepam—GABRR1—nerve—type 2 diabetes mellitus	0.00262	0.0852	CbGeAlD
Bromazepam—GABRR3—retina—type 2 diabetes mellitus	0.0013	0.0423	CbGeAlD
Bromazepam—GABRR2—retina—type 2 diabetes mellitus	0.00113	0.0367	CbGeAlD
Bromazepam—GABRR1—retina—type 2 diabetes mellitus	0.00109	0.0353	CbGeAlD
Bromazepam—GABRB3—islet of Langerhans—type 2 diabetes mellitus	0.000597	0.0194	CbGeAlD
Bromazepam—GABRA2—cortex of kidney—type 2 diabetes mellitus	0.00049	0.0159	CbGeAlD
Bromazepam—GABRA2—adipose tissue—type 2 diabetes mellitus	0.000453	0.0147	CbGeAlD
Bromazepam—GABRE—adipose tissue—type 2 diabetes mellitus	0.000449	0.0146	CbGeAlD
Bromazepam—GABRB3—pancreas—type 2 diabetes mellitus	0.00042	0.0136	CbGeAlD
Bromazepam—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000306	0.00995	CbGeAlD
Bromazepam—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000275	0.00893	CbGeAlD
Bromazepam—CYP2E1—kidney—type 2 diabetes mellitus	0.000269	0.00874	CbGeAlD
Bromazepam—GABRB3—liver—type 2 diabetes mellitus	0.000267	0.00868	CbGeAlD
Bromazepam—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000262	0.00851	CbGeAlD
Bromazepam—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.00026	0.00159	CcSEcCtD
Bromazepam—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000258	0.00158	CcSEcCtD
Bromazepam—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000258	0.00158	CcSEcCtD
Bromazepam—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000258	0.00158	CcSEcCtD
Bromazepam—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00156	CcSEcCtD
Bromazepam—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000255	0.00156	CcSEcCtD
Bromazepam—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000254	0.00156	CcSEcCtD
Bromazepam—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000253	0.00155	CcSEcCtD
Bromazepam—Anorexia—Glyburide—type 2 diabetes mellitus	0.000253	0.00155	CcSEcCtD
Bromazepam—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000253	0.00155	CcSEcCtD
Bromazepam—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000253	0.00154	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000251	0.00153	CcSEcCtD
Bromazepam—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00153	CcSEcCtD
Bromazepam—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00025	0.00153	CcSEcCtD
Bromazepam—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000249	0.00152	CcSEcCtD
Bromazepam—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000248	0.00152	CcSEcCtD
Bromazepam—Hypotension—Glyburide—type 2 diabetes mellitus	0.000248	0.00152	CcSEcCtD
Bromazepam—Nausea—Repaglinide—type 2 diabetes mellitus	0.000248	0.00152	CcSEcCtD
Bromazepam—Asthenia—Glipizide—type 2 diabetes mellitus	0.000248	0.00151	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000247	0.00151	CcSEcCtD
Bromazepam—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000247	0.00151	CcSEcCtD
Bromazepam—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000246	0.0015	CcSEcCtD
Bromazepam—Clonazepam—CYP2E1—type 2 diabetes mellitus	0.000246	0.168	CrCbGaD
Bromazepam—Malnutrition—Metformin—type 2 diabetes mellitus	0.000244	0.0015	CcSEcCtD
Bromazepam—Pruritus—Glipizide—type 2 diabetes mellitus	0.000244	0.00149	CcSEcCtD
Bromazepam—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000244	0.00149	CcSEcCtD
Bromazepam—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000243	0.00149	CcSEcCtD
Bromazepam—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00024	0.00147	CcSEcCtD
Bromazepam—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000239	0.00146	CcSEcCtD
Bromazepam—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000237	0.00145	CcSEcCtD
Bromazepam—Palpitations—Valsartan—type 2 diabetes mellitus	0.000237	0.00145	CcSEcCtD
Bromazepam—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000237	0.00145	CcSEcCtD
Bromazepam—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00145	CcSEcCtD
Bromazepam—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000235	0.00144	CcSEcCtD
Bromazepam—Palpitations—Orlistat—type 2 diabetes mellitus	0.000234	0.00143	CcSEcCtD
Bromazepam—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000234	0.00143	CcSEcCtD
Bromazepam—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000234	0.00143	CcSEcCtD
Bromazepam—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000234	0.00143	CcSEcCtD
Bromazepam—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000233	0.00142	CcSEcCtD
Bromazepam—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000232	0.00142	CcSEcCtD
Bromazepam—CYP2C19—liver—type 2 diabetes mellitus	0.000231	0.00752	CbGeAlD
Bromazepam—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000231	0.00141	CcSEcCtD
Bromazepam—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000231	0.00141	CcSEcCtD
Bromazepam—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000231	0.00141	CcSEcCtD
Bromazepam—Vision blurred—Metformin—type 2 diabetes mellitus	0.00023	0.00141	CcSEcCtD
Bromazepam—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00023	0.00141	CcSEcCtD
Bromazepam—Convulsion—Orlistat—type 2 diabetes mellitus	0.00023	0.00141	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000229	0.0014	CcSEcCtD
Bromazepam—Tremor—Metformin—type 2 diabetes mellitus	0.000229	0.0014	CcSEcCtD
Bromazepam—Dizziness—Glipizide—type 2 diabetes mellitus	0.000228	0.0014	CcSEcCtD
Bromazepam—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000228	0.00139	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000227	0.00139	CcSEcCtD
Bromazepam—Tension—Irbesartan—type 2 diabetes mellitus	0.000226	0.00138	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000224	0.00137	CcSEcCtD
Bromazepam—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000224	0.00137	CcSEcCtD
Bromazepam—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000224	0.00137	CcSEcCtD
Bromazepam—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000223	0.00136	CcSEcCtD
Bromazepam—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000222	0.00136	CcSEcCtD
Bromazepam—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000221	0.00135	CcSEcCtD
Bromazepam—Vomiting—Glipizide—type 2 diabetes mellitus	0.000219	0.00134	CcSEcCtD
Bromazepam—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000219	0.00134	CcSEcCtD
Bromazepam—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000219	0.00134	CcSEcCtD
Bromazepam—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000219	0.00134	CcSEcCtD
Bromazepam—Rash—Glipizide—type 2 diabetes mellitus	0.000218	0.00133	CcSEcCtD
Bromazepam—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000217	0.00133	CcSEcCtD
Bromazepam—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000217	0.00133	CcSEcCtD
Bromazepam—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000216	0.00132	CcSEcCtD
Bromazepam—CYP3A4—kidney—type 2 diabetes mellitus	0.000216	0.00703	CbGeAlD
Bromazepam—Headache—Glipizide—type 2 diabetes mellitus	0.000216	0.00132	CcSEcCtD
Bromazepam—Tremor—Irbesartan—type 2 diabetes mellitus	0.000216	0.00132	CcSEcCtD
Bromazepam—Palpitations—Metformin—type 2 diabetes mellitus	0.000216	0.00132	CcSEcCtD
Bromazepam—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000215	0.00131	CcSEcCtD
Bromazepam—Tension—Losartan—type 2 diabetes mellitus	0.000213	0.0013	CcSEcCtD
Bromazepam—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000213	0.0013	CcSEcCtD
Bromazepam—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000213	0.0013	CcSEcCtD
Bromazepam—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000212	0.0013	CcSEcCtD
Bromazepam—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000212	0.0013	CcSEcCtD
Bromazepam—Agitation—Irbesartan—type 2 diabetes mellitus	0.000212	0.0013	CcSEcCtD
Bromazepam—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000212	0.0013	CcSEcCtD
Bromazepam—Nervousness—Losartan—type 2 diabetes mellitus	0.000211	0.00129	CcSEcCtD
Bromazepam—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00021	0.00129	CcSEcCtD
Bromazepam—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00021	0.00129	CcSEcCtD
Bromazepam—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00021	0.00128	CcSEcCtD
Bromazepam—Anorexia—Valsartan—type 2 diabetes mellitus	0.000209	0.00128	CcSEcCtD
Bromazepam—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000209	0.00128	CcSEcCtD
Bromazepam—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000208	0.00128	CcSEcCtD
Bromazepam—Headache—Pioglitazone—type 2 diabetes mellitus	0.000207	0.00127	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000207	0.00126	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000206	0.00126	CcSEcCtD
Bromazepam—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000206	0.00126	CcSEcCtD
Bromazepam—Nausea—Glipizide—type 2 diabetes mellitus	0.000205	0.00125	CcSEcCtD
Bromazepam—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000205	0.00125	CcSEcCtD
Bromazepam—Hypotension—Valsartan—type 2 diabetes mellitus	0.000205	0.00125	CcSEcCtD
Bromazepam—Vision blurred—Losartan—type 2 diabetes mellitus	0.000205	0.00125	CcSEcCtD
Bromazepam—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00125	CcSEcCtD
Bromazepam—Tremor—Losartan—type 2 diabetes mellitus	0.000203	0.00124	CcSEcCtD
Bromazepam—Rash—Glimepiride—type 2 diabetes mellitus	0.000203	0.00124	CcSEcCtD
Bromazepam—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000203	0.00124	CcSEcCtD
Bromazepam—Rash—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00124	CcSEcCtD
Bromazepam—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00124	CcSEcCtD
Bromazepam—Headache—Glimepiride—type 2 diabetes mellitus	0.000202	0.00123	CcSEcCtD
Bromazepam—Headache—Sitagliptin—type 2 diabetes mellitus	0.000201	0.00123	CcSEcCtD
Bromazepam—Agitation—Losartan—type 2 diabetes mellitus	0.0002	0.00122	CcSEcCtD
Bromazepam—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000196	0.0012	CcSEcCtD
Bromazepam—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000196	0.0012	CcSEcCtD
Bromazepam—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000196	0.0012	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000195	0.00119	CcSEcCtD
Bromazepam—Somnolence—Valsartan—type 2 diabetes mellitus	0.000195	0.00119	CcSEcCtD
Bromazepam—Skin disorder—Metformin—type 2 diabetes mellitus	0.000194	0.00119	CcSEcCtD
Bromazepam—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000193	0.00118	CcSEcCtD
Bromazepam—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00118	CcSEcCtD
Bromazepam—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000192	0.00118	CcSEcCtD
Bromazepam—Palpitations—Losartan—type 2 diabetes mellitus	0.000192	0.00117	CcSEcCtD
Bromazepam—Nausea—Glimepiride—type 2 diabetes mellitus	0.000191	0.00117	CcSEcCtD
Bromazepam—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000191	0.00117	CcSEcCtD
Bromazepam—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000191	0.00117	CcSEcCtD
Bromazepam—Asthenia—Glyburide—type 2 diabetes mellitus	0.000191	0.00117	CcSEcCtD
Bromazepam—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00019	0.00117	CcSEcCtD
Bromazepam—Anorexia—Metformin—type 2 diabetes mellitus	0.00019	0.00116	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000189	0.00116	CcSEcCtD
Bromazepam—CYP1A2—liver—type 2 diabetes mellitus	0.000189	0.00614	CbGeAlD
Bromazepam—Fatigue—Valsartan—type 2 diabetes mellitus	0.000189	0.00116	CcSEcCtD
Bromazepam—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000188	0.00115	CcSEcCtD
Bromazepam—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000188	0.00115	CcSEcCtD
Bromazepam—Pruritus—Glyburide—type 2 diabetes mellitus	0.000188	0.00115	CcSEcCtD
Bromazepam—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000187	0.00115	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000187	0.00114	CcSEcCtD
Bromazepam—Fatigue—Orlistat—type 2 diabetes mellitus	0.000187	0.00114	CcSEcCtD
Bromazepam—Hypotension—Metformin—type 2 diabetes mellitus	0.000186	0.00114	CcSEcCtD
Bromazepam—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000186	0.00114	CcSEcCtD
Bromazepam—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000185	0.00113	CcSEcCtD
Bromazepam—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000185	0.00113	CcSEcCtD
Bromazepam—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00112	CcSEcCtD
Bromazepam—Rash—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00112	CcSEcCtD
Bromazepam—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00112	CcSEcCtD
Bromazepam—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000183	0.00112	CcSEcCtD
Bromazepam—Tension—Ramipril—type 2 diabetes mellitus	0.000183	0.00112	CcSEcCtD
Bromazepam—Headache—Bromocriptine—type 2 diabetes mellitus	0.000182	0.00111	CcSEcCtD
Bromazepam—Nervousness—Ramipril—type 2 diabetes mellitus	0.000181	0.00111	CcSEcCtD
Bromazepam—Dry mouth—Losartan—type 2 diabetes mellitus	0.000181	0.00111	CcSEcCtD
Bromazepam—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000179	0.0011	CcSEcCtD
Bromazepam—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000179	0.00109	CcSEcCtD
Bromazepam—Confusional state—Losartan—type 2 diabetes mellitus	0.000179	0.00109	CcSEcCtD
Bromazepam—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000178	0.00109	CcSEcCtD
Bromazepam—Nitrazepam—CYP2E1—type 2 diabetes mellitus	0.000178	0.122	CrCbGaD
Bromazepam—Somnolence—Metformin—type 2 diabetes mellitus	0.000177	0.00109	CcSEcCtD
Bromazepam—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000177	0.00108	CcSEcCtD
Bromazepam—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000176	0.00108	CcSEcCtD
Bromazepam—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000176	0.00107	CcSEcCtD
Bromazepam—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000176	0.00107	CcSEcCtD
Bromazepam—Tremor—Ramipril—type 2 diabetes mellitus	0.000174	0.00107	CcSEcCtD
Bromazepam—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000174	0.00106	CcSEcCtD
Bromazepam—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000173	0.00106	CcSEcCtD
Bromazepam—Tachycardia—Losartan—type 2 diabetes mellitus	0.000173	0.00106	CcSEcCtD
Bromazepam—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00106	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000172	0.00105	CcSEcCtD
Bromazepam—Fatigue—Metformin—type 2 diabetes mellitus	0.000172	0.00105	CcSEcCtD
Bromazepam—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000171	0.00105	CcSEcCtD
Bromazepam—Agitation—Ramipril—type 2 diabetes mellitus	0.000171	0.00105	CcSEcCtD
Bromazepam—CYP2E1—liver—type 2 diabetes mellitus	0.00017	0.00552	CbGeAlD
Bromazepam—Anorexia—Losartan—type 2 diabetes mellitus	0.000169	0.00103	CcSEcCtD
Bromazepam—Vomiting—Glyburide—type 2 diabetes mellitus	0.000169	0.00103	CcSEcCtD
Bromazepam—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000169	0.00103	CcSEcCtD
Bromazepam—Rash—Glyburide—type 2 diabetes mellitus	0.000167	0.00102	CcSEcCtD
Bromazepam—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000167	0.00102	CcSEcCtD
Bromazepam—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000167	0.00102	CcSEcCtD
Bromazepam—Headache—Glyburide—type 2 diabetes mellitus	0.000166	0.00102	CcSEcCtD
Bromazepam—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000166	0.00101	CcSEcCtD
Bromazepam—Hypotension—Losartan—type 2 diabetes mellitus	0.000166	0.00101	CcSEcCtD
Bromazepam—Palpitations—Ramipril—type 2 diabetes mellitus	0.000165	0.00101	CcSEcCtD
Bromazepam—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000164	0.00101	CcSEcCtD
Bromazepam—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000164	0.001	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000163	0.000994	CcSEcCtD
Bromazepam—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000162	0.000993	CcSEcCtD
Bromazepam—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000161	0.000987	CcSEcCtD
Bromazepam—Convulsion—Ramipril—type 2 diabetes mellitus	0.000161	0.000987	CcSEcCtD
Bromazepam—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000159	0.000976	CcSEcCtD
Bromazepam—Nausea—Glyburide—type 2 diabetes mellitus	0.000158	0.000965	CcSEcCtD
Bromazepam—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000158	0.000965	CcSEcCtD
Bromazepam—Somnolence—Losartan—type 2 diabetes mellitus	0.000158	0.000964	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000157	0.000963	CcSEcCtD
Bromazepam—Asthenia—Valsartan—type 2 diabetes mellitus	0.000157	0.000962	CcSEcCtD
Bromazepam—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000156	0.000954	CcSEcCtD
Bromazepam—Asthenia—Orlistat—type 2 diabetes mellitus	0.000155	0.00095	CcSEcCtD
Bromazepam—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000155	0.000949	CcSEcCtD
Bromazepam—Pruritus—Valsartan—type 2 diabetes mellitus	0.000155	0.000948	CcSEcCtD
Bromazepam—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000155	0.000948	CcSEcCtD
Bromazepam—Clonazepam—CYP3A4—type 2 diabetes mellitus	0.000155	0.106	CrCbGaD
Bromazepam—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000154	0.000942	CcSEcCtD
Bromazepam—Confusional state—Ramipril—type 2 diabetes mellitus	0.000153	0.000937	CcSEcCtD
Bromazepam—Pruritus—Orlistat—type 2 diabetes mellitus	0.000153	0.000937	CcSEcCtD
Bromazepam—Fatigue—Losartan—type 2 diabetes mellitus	0.000153	0.000935	CcSEcCtD
Bromazepam—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000152	0.000929	CcSEcCtD
Bromazepam—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000152	0.000928	CcSEcCtD
Bromazepam—Rash—Gliclazide—type 2 diabetes mellitus	0.00015	0.00092	CcSEcCtD
Bromazepam—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00015	0.000919	CcSEcCtD
Bromazepam—Clorazepate—CYP3A4—type 2 diabetes mellitus	0.00015	0.102	CrCbGaD
Bromazepam—Headache—Gliclazide—type 2 diabetes mellitus	0.000149	0.000914	CcSEcCtD
Bromazepam—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000149	0.000912	CcSEcCtD
Bromazepam—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000148	0.000907	CcSEcCtD
Bromazepam—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000148	0.000903	CcSEcCtD
Bromazepam—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000146	0.000893	CcSEcCtD
Bromazepam—Dizziness—Valsartan—type 2 diabetes mellitus	0.000145	0.000886	CcSEcCtD
Bromazepam—Anorexia—Ramipril—type 2 diabetes mellitus	0.000145	0.000886	CcSEcCtD
Bromazepam—Dizziness—Orlistat—type 2 diabetes mellitus	0.000143	0.000876	CcSEcCtD
Bromazepam—Asthenia—Metformin—type 2 diabetes mellitus	0.000143	0.000876	CcSEcCtD
Bromazepam—Hypotension—Ramipril—type 2 diabetes mellitus	0.000142	0.000869	CcSEcCtD
Bromazepam—Nausea—Gliclazide—type 2 diabetes mellitus	0.000142	0.000867	CcSEcCtD
Bromazepam—Pruritus—Metformin—type 2 diabetes mellitus	0.000141	0.000864	CcSEcCtD
Bromazepam—Vomiting—Valsartan—type 2 diabetes mellitus	0.000139	0.000852	CcSEcCtD
Bromazepam—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000139	0.000849	CcSEcCtD
Bromazepam—Rash—Valsartan—type 2 diabetes mellitus	0.000138	0.000845	CcSEcCtD
Bromazepam—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000138	0.000844	CcSEcCtD
Bromazepam—Vomiting—Orlistat—type 2 diabetes mellitus	0.000138	0.000842	CcSEcCtD
Bromazepam—Headache—Valsartan—type 2 diabetes mellitus	0.000137	0.00084	CcSEcCtD
Bromazepam—CYP3A4—liver—type 2 diabetes mellitus	0.000137	0.00444	CbGeAlD
Bromazepam—Rash—Orlistat—type 2 diabetes mellitus	0.000136	0.000835	CcSEcCtD
Bromazepam—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000136	0.000834	CcSEcCtD
Bromazepam—Headache—Orlistat—type 2 diabetes mellitus	0.000136	0.00083	CcSEcCtD
Bromazepam—Clonazepam—ALB—type 2 diabetes mellitus	0.000135	0.0921	CrCbGaD
Bromazepam—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000826	CcSEcCtD
Bromazepam—Somnolence—Ramipril—type 2 diabetes mellitus	0.000135	0.000826	CcSEcCtD
Bromazepam—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000134	0.000818	CcSEcCtD
Bromazepam—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000133	0.000815	CcSEcCtD
Bromazepam—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000132	0.000808	CcSEcCtD
Bromazepam—Dizziness—Metformin—type 2 diabetes mellitus	0.000132	0.000807	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.000802	CcSEcCtD
Bromazepam—Fatigue—Ramipril—type 2 diabetes mellitus	0.000131	0.000801	CcSEcCtD
Bromazepam—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000131	0.000799	CcSEcCtD
Bromazepam—Nausea—Valsartan—type 2 diabetes mellitus	0.00013	0.000796	CcSEcCtD
Bromazepam—Nausea—Orlistat—type 2 diabetes mellitus	0.000129	0.000787	CcSEcCtD
Bromazepam—Asthenia—Losartan—type 2 diabetes mellitus	0.000127	0.000778	CcSEcCtD
Bromazepam—Vomiting—Metformin—type 2 diabetes mellitus	0.000127	0.000776	CcSEcCtD
Bromazepam—Diazepam—CYP2E1—type 2 diabetes mellitus	0.000126	0.0858	CrCbGaD
Bromazepam—Rash—Metformin—type 2 diabetes mellitus	0.000126	0.00077	CcSEcCtD
Bromazepam—Dermatitis—Metformin—type 2 diabetes mellitus	0.000126	0.000769	CcSEcCtD
Bromazepam—Pruritus—Losartan—type 2 diabetes mellitus	0.000125	0.000767	CcSEcCtD
Bromazepam—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000125	0.000766	CcSEcCtD
Bromazepam—Headache—Metformin—type 2 diabetes mellitus	0.000125	0.000765	CcSEcCtD
Bromazepam—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000125	0.000762	CcSEcCtD
Bromazepam—Diazepam—CYP1A2—type 2 diabetes mellitus	0.00012	0.0816	CrCbGaD
Bromazepam—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00012	0.000732	CcSEcCtD
Bromazepam—Rash—Irbesartan—type 2 diabetes mellitus	0.000119	0.000726	CcSEcCtD
Bromazepam—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000119	0.000726	CcSEcCtD
Bromazepam—Nausea—Metformin—type 2 diabetes mellitus	0.000119	0.000725	CcSEcCtD
Bromazepam—Headache—Irbesartan—type 2 diabetes mellitus	0.000118	0.000722	CcSEcCtD
Bromazepam—Dizziness—Losartan—type 2 diabetes mellitus	0.000117	0.000717	CcSEcCtD
Bromazepam—Vomiting—Losartan—type 2 diabetes mellitus	0.000113	0.000689	CcSEcCtD
Bromazepam—Nitrazepam—CYP3A4—type 2 diabetes mellitus	0.000112	0.0765	CrCbGaD
Bromazepam—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000112	0.000685	CcSEcCtD
Bromazepam—Nausea—Irbesartan—type 2 diabetes mellitus	0.000112	0.000684	CcSEcCtD
Bromazepam—Rash—Losartan—type 2 diabetes mellitus	0.000112	0.000683	CcSEcCtD
Bromazepam—Dermatitis—Losartan—type 2 diabetes mellitus	0.000112	0.000683	CcSEcCtD
Bromazepam—Headache—Losartan—type 2 diabetes mellitus	0.000111	0.000679	CcSEcCtD
Bromazepam—Asthenia—Ramipril—type 2 diabetes mellitus	0.000109	0.000667	CcSEcCtD
Bromazepam—Pruritus—Ramipril—type 2 diabetes mellitus	0.000107	0.000658	CcSEcCtD
Bromazepam—Nausea—Losartan—type 2 diabetes mellitus	0.000105	0.000644	CcSEcCtD
Bromazepam—Dizziness—Ramipril—type 2 diabetes mellitus	0.0001	0.000615	CcSEcCtD
Bromazepam—Oxazepam—CYP3A4—type 2 diabetes mellitus	9.67e-05	0.0659	CrCbGaD
Bromazepam—Vomiting—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000591	CcSEcCtD
Bromazepam—Rash—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000586	CcSEcCtD
Bromazepam—Dermatitis—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000586	CcSEcCtD
Bromazepam—Headache—Ramipril—type 2 diabetes mellitus	9.52e-05	0.000582	CcSEcCtD
Bromazepam—Nausea—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000552	CcSEcCtD
Bromazepam—Diazepam—CYP3A4—type 2 diabetes mellitus	7.93e-05	0.054	CrCbGaD
Bromazepam—Diazepam—ALB—type 2 diabetes mellitus	6.92e-05	0.0471	CrCbGaD
Bromazepam—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	7.01e-06	8.15e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	7.01e-06	8.15e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	7.01e-06	8.15e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.97e-06	8.11e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.85e-06	7.96e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	6.81e-06	7.92e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	6.81e-06	7.92e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	6.81e-06	7.92e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	6.81e-06	7.92e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	6.77e-06	7.87e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	6.72e-06	7.81e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	6.72e-06	7.81e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	6.58e-06	7.66e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	6.58e-06	7.66e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.55e-06	7.62e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	6.53e-06	7.6e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	6.46e-06	7.52e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	6.46e-06	7.52e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	6.36e-06	7.39e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	6.36e-06	7.39e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.36e-06	7.39e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	6.36e-06	7.39e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	6.36e-06	7.39e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	6.35e-06	7.39e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	6.35e-06	7.38e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.34e-06	7.38e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	6.29e-06	7.32e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	6.29e-06	7.32e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	6.29e-06	7.32e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	6.24e-06	7.26e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	6.24e-06	7.26e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	6.24e-06	7.26e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.22e-06	7.23e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	6.18e-06	7.18e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.16e-06	7.16e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.15e-06	7.15e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	6.12e-06	7.12e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	6.07e-06	7.06e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.05e-06	7.04e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.99e-06	6.97e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	5.87e-06	6.83e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.82e-06	6.76e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.82e-06	6.76e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	5.78e-06	6.72e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.69e-06	6.62e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.69e-06	6.62e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	5.67e-06	6.59e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.67e-06	6.59e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.64e-06	6.56e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	5.55e-06	6.46e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	5.55e-06	6.46e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.55e-06	6.45e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	5.5e-06	6.39e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.49e-06	6.39e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	5.46e-06	6.35e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.46e-06	6.35e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	5.45e-06	6.33e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.42e-06	6.3e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	5.41e-06	6.3e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	5.41e-06	6.3e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	5.41e-06	6.3e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.41e-06	6.29e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.41e-06	6.29e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.41e-06	6.29e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	5.38e-06	6.26e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	5.31e-06	6.17e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	5.31e-06	6.17e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	5.31e-06	6.17e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	5.31e-06	6.17e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	5.28e-06	6.14e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.22e-06	6.07e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.18e-06	6.03e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.18e-06	6.03e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.1e-06	5.94e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.09e-06	5.92e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.99e-06	5.8e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.99e-06	5.8e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	4.94e-06	5.75e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.9e-06	5.7e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.87e-06	5.66e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.85e-06	5.65e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.85e-06	5.65e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.85e-06	5.65e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.84e-06	5.63e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.82e-06	5.6e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.82e-06	5.6e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.82e-06	5.6e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.79e-06	5.57e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.77e-06	5.54e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.73e-06	5.5e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.72e-06	5.49e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.7e-06	5.47e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.7e-06	5.47e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.68e-06	5.44e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.66e-06	5.42e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.62e-06	5.38e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.62e-06	5.37e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.53e-06	5.27e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.48e-06	5.21e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.44e-06	5.16e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.42e-06	5.14e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.39e-06	5.11e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.39e-06	5.11e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.36e-06	5.07e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.33e-06	5.03e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.33e-06	5.03e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.28e-06	4.98e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.28e-06	4.98e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.26e-06	4.95e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.24e-06	4.94e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.24e-06	4.93e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.22e-06	4.91e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.22e-06	4.91e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.22e-06	4.91e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.22e-06	4.91e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.21e-06	4.9e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.21e-06	4.9e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.19e-06	4.87e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	4.19e-06	4.87e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	4.18e-06	4.86e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.12e-06	4.79e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.1e-06	4.77e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.1e-06	4.77e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.1e-06	4.77e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.1e-06	4.77e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.07e-06	4.73e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	4.07e-06	4.73e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.02e-06	4.67e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.93e-06	4.57e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.85e-06	4.48e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.79e-06	4.41e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.78e-06	4.4e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.78e-06	4.4e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.78e-06	4.4e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.78e-06	4.4e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.71e-06	4.32e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.68e-06	4.28e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.66e-06	4.26e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.65e-06	4.25e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.63e-06	4.22e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.63e-06	4.22e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.63e-06	4.22e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.61e-06	4.2e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.6e-06	4.19e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.6e-06	4.19e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.59e-06	4.17e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.56e-06	4.14e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.55e-06	4.13e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.46e-06	4.02e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.46e-06	4.02e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.42e-06	3.98e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.41e-06	3.97e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.37e-06	3.91e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.34e-06	3.88e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.34e-06	3.88e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.34e-06	3.88e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.32e-06	3.86e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.3e-06	3.84e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.28e-06	3.81e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.28e-06	3.81e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.28e-06	3.81e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.25e-06	3.79e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.25e-06	3.79e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.25e-06	3.79e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.23e-06	3.76e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.23e-06	3.76e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.22e-06	3.75e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.18e-06	3.69e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.14e-06	3.65e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.14e-06	3.65e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-06	3.64e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.1e-06	3.6e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.07e-06	3.57e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.97e-06	3.46e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.92e-06	3.4e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.92e-06	3.4e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.92e-06	3.4e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.92e-06	3.39e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.87e-06	3.33e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.84e-06	3.3e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.83e-06	3.29e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.83e-06	3.29e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.83e-06	3.29e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.81e-06	3.27e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.81e-06	3.27e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.78e-06	3.23e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.78e-06	3.23e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.78e-06	3.23e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.77e-06	3.22e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.74e-06	3.18e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.7e-06	3.13e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.69e-06	3.13e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.69e-06	3.13e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.67e-06	3.11e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.64e-06	3.07e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.64e-06	3.07e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.62e-06	3.05e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.57e-06	2.99e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.53e-06	2.94e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.53e-06	2.94e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.52e-06	2.93e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.51e-06	2.92e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.46e-06	2.86e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.45e-06	2.84e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.41e-06	2.81e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.41e-06	2.8e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	2.75e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.32e-06	2.7e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-06	2.64e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.2e-06	2.56e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.18e-06	2.54e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.18e-06	2.54e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.17e-06	2.53e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	2.52e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	2.52e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.16e-06	2.51e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.14e-06	2.49e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	2.48e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.08e-06	2.42e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.07e-06	2.41e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.07e-06	2.41e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.02e-06	2.35e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.99e-06	2.31e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.94e-06	2.26e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.94e-06	2.25e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	2.21e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.89e-06	2.19e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-06	2.19e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.86e-06	2.17e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	2.14e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.79e-06	2.08e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.75e-06	2.04e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.7e-06	1.98e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	1.97e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.67e-06	1.94e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.66e-06	1.94e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.65e-06	1.91e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.62e-06	1.88e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.62e-06	1.88e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	1.72e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.45e-06	1.69e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.42e-06	1.65e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.3e-06	1.52e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	1.44e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.14e-06	1.33e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.53e-07	1.11e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.43e-07	8.64e-06	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.73e-07	6.67e-06	CbGpPWpGaD
